Overall, these data support the notion that METTL3-catalyzed m6A methylation can affect the activities of certain tumor-specific mRNAs, eliciting a change in the expression of the oncoproteins and biological behaviors of the tumor cells and facilitating the cancer development. The gene discussed is METTL3; the disease is neoplasm.